|
 
- 积分
- 460
- 威望
- 460
- 包包
- 1467
|

1.Bastian, P. J., J. Ellinger, et al. (2004). "GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?" Eur J Med Res 9(11): 523-527.
; A8 ^9 z+ {8 F! j: G2 S' `/ i2.Bastian, P. J., M. Nakayama, et al. (2004). "[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer]." Urologe A 43(5): 573-579.. ]6 k! {' b! w# i' s; C
3.Bastian, P. J., G. S. Palapattu, et al. (2008). "CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer." J Urol 179(2): 529-534; discussion 534-525.- t7 n4 T, R Z; ?- T7 d) J
4.Bernardini, S., R. Miano, et al. (2004). "Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?" Clin Chim Acta 350(1-2): 181-188.3 u# V- Q/ L& d' _; _! i
5.Bryzgunova, O. E., E. S. Morozkin, et al. (2008). "Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients." Ann N Y Acad Sci 1137: 222-225.
9 j$ }# ~! c& G5 E! x: b6.Chu, D. C., C. K. Chuang, et al. (2002). "The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma." J Urol 167(4): 1854-1858.
$ i3 b5 r- l+ w! k; ?- X7.Chuang, C. K., D. C. Chu, et al. (2007). "Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma." Cancer Detect Prev 31(1): 59-63.
5 b# J: o h* f8.Crocitto, L. E., D. Korns, et al. (2004). "Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results." Urology 64(4): 821-825." V* [; X4 f' f: ^7 W
9.De Marzo, A. M., A. K. Meeker, et al. (2003). "Human prostate cancer precursors and pathobiology." Urology 62(5 Suppl 1): 55-62.
/ U9 ^7 @8 m2 i7 B6 F) z; i) u0 f10.Devaney, J., C. Stirzaker, et al. (2011). "Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides 11.a regional panel of novel DNA methylation cancer biomarkers." Cancer Epidemiol Biomarkers Prev 20(1): 148-159.
2 Z3 Z# J% b, a6 P1 J% L12.Eilers, T., S. Machtens, et al. (2007). "Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate." Prostate 67(7): 757-763.
9 E) x) ?3 W- f% I+ O* B13.Goessl, C., M. Muller, et al. (2001). "DNA-based detection of prostate cancer in blood, urine, and ejaculates." Ann N Y Acad Sci 945: 51-58.
6 ~2 |9 f: ]1 I# }. u3 _14.Goessl, C., M. Muller, et al. (2002). "Methylation-specific PCR for detection of neoplastic DNA in biopsy washings." J Pathol 196(3): 331-334.- Q8 V! T( y* k& t. n. Q
15.Goessl, C., M. Muller, et al. (2001). "DNA-based detection of prostate cancer in urine after prostatic massage." Urology 58(3): 335-338., I# W% K0 c! r2 s
16.Gonzalgo, M. L., M. Nakayama, et al. (2004). "Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis." Urology 63(2): 414-418., K0 y5 e" c8 S1 c6 j
17.Harden, S. V., Z. Guo, et al. (2003). "Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma." J Urol 169(3): 1138-1142.
5 }3 }, @* w8 ]! q- Q; `$ s小弟学校条件比较差,请高手帮助。非恶意一次要求这么多文献求助。
- w6 `# v& ?, D$ _6 qHarden, S. V., H. Sanderson, et al. (2003). "Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies." J Natl Cancer Inst 95(21): 1634-1637.. @8 `8 t8 m/ d
|
|